Altman Z-Score
-4.82
+0.01+0.21%
Fri, 07 Mar 2025 21:01:47 GMT
Summary
- As of March 8, 2025, RNAC Altman Z-Score is -4.82, with the most recent change of +0.01 (+0.21%) on March 7, 2025.
- RNAC current Altman Z-Score indicates the stock has a high bankruptcy risk.
Performance
RNAC Altman Z-Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Altman Z-Score Formula
Z-Score = 1.2*A + 1.4*B + 3.3*C + 0.6*D + 1.0*E- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
RNAC Altman Z-Score Trends
PeriodPeriod | Altman Z-ScoreAltman Z-Score | PricePrice | Market capMarket cap |
---|---|---|---|
todaytoday | +0.2% | +3.1% | +3.1% |
1 m1 month | 0.0% | +0.2% | +0.2% |
3 m3 months | -2.5% | -24.0% | -24.0% |
6 m6 months | +3.0% | +37.3% | +65.2% |
ytdytd | +0.2% | +2.7% | +2.7% |
1 y1 year | +5.7% | -4.8% | +353.9% |
5 y5 years | -37.7% | -84.1% | +41.9% |
Cartesian Therapeutics Altman Z-Score History
Date | Value |
---|---|
2025 | -4.82(-0.2%) |
2024 | -4.83(-5.5%) |
2023 | -5.11(-1316.7%) |
2022 | 0.42(-138.9%) |
2021 | -1.08(-65.0%) |
Date | Value |
---|---|
2020 | -3.09(-28.8%) |
2019 | -4.34(-65.7%) |
2018 | -12.64(+815.9%) |
2017 | -1.38(-147.1%) |
2016 | 2.93 |
FAQ
- What is Cartesian Therapeutics altman z-score?
- What is RNAC altman z-score year-to-date change?
- What is Cartesian Therapeutics altman z-score year-on-year change?
What is Cartesian Therapeutics altman z-score?
The current altman z-score of RNAC is -4.82
What is RNAC altman z-score year-to-date change?
Cartesian Therapeutics altman z-score has changed by +0.01 (+0.21%) since the beginning of the year
What is Cartesian Therapeutics altman z-score year-on-year change?
Over the past year, RNAC altman z-score has changed by +0.29 (+5.68%)